Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K

被引:53
作者
Marquis, RW
Ru, Y
Yamashita, DS
Oh, HJ
Yen, J
Thompson, SK
Carr, TJ
Levy, MA
Tomaszek, TA
Ijames, CF
Smith, WW
Zhao, BG
Janson, CA
Abdel-Meguid, SS
D'Alessio, KJ
McQueney, MS
Veber, DF
机构
[1] SmithKline Beecham Pharmaceut, Dept Med Chem, King Of Prussia, PA 19406 USA
[2] SmithKline Beecham Pharmaceut, Dept Mol Recognit, King Of Prussia, PA 19406 USA
[3] SmithKline Beecham Pharmaceut, Dept Phys & Struct Chem, King Of Prussia, PA 19406 USA
[4] SmithKline Beecham Pharmaceut, Dept Biol Struct, King Of Prussia, PA 19406 USA
[5] SmithKline Beecham Pharmaceut, Dept Prot Biochem, King Of Prussia, PA 19406 USA
关键词
cysteine protease; cathepsin K; enzyme inhibitor; alkoxymethylketone; thiomethylketone;
D O I
10.1016/S0968-0896(99)00011-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cathepsin K (EC 3.4.22.38) is a cysteine protease of the papain superfamily which is selectively expressed within the osteoclast. Several lines of evidence have pointed to the fact that this protease may play an important role in the degradation of the bone matrix. Potent and selective inhibitors of cathepsin K could be important therapeutic agents for the control of excessive bone resorption. Recently a series of peptide aldehydes have been shown to be potent inhibitors of cathepsin K. In an effort to design more selective and metabolically stable inhibitors of cathepsin K, a series of electronically attenuated alkoxymethylketones and thiomethylketones inhibitors have been synthesized. The X-ray co-crystal structure of one of these analogues in complex with cathepsin K shows the inhibitor binding in the primed side of the enzyme active site with a covalent interaction between the active site cysteine 25 and the carbonyl carbon of the inhibitor. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:581 / 588
页数:8
相关论文
共 26 条
[1]   Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification [J].
Bossard, MJ ;
Tomaszek, TA ;
Thompson, SK ;
Amegadzie, BY ;
Hanning, CR ;
Jones, C ;
Kurdyla, JT ;
McNulty, DE ;
Drake, FH ;
Gowen, M ;
Levy, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12517-12524
[2]  
BROMME D, 1996, BIOL CHEM HOPPESEYLE, V376, P379
[3]   THE DAKIN-WEST REACTION [J].
BUCHANAN, GL .
CHEMICAL SOCIETY REVIEWS, 1988, 17 (02) :91-109
[4]  
CARR TJ, Patent No. 9716433
[5]  
DOLLE RE, Patent No. 9641638
[6]   Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts [J].
Drake, FH ;
Dodds, RA ;
James, IE ;
Connor, JR ;
Debouck, C ;
Richardson, S ;
LeeRykaczewski, E ;
Coleman, L ;
Rieman, D ;
Barthlow, R ;
Hastings, G ;
Gowen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12511-12516
[7]   Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency [J].
Gelb, BD ;
Shi, GP ;
Chapman, HA ;
Desnick, RJ .
SCIENCE, 1996, 273 (5279) :1236-1238
[8]   Cathepsin K: Isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene [J].
Gelb, BD ;
Moissoglu, K ;
Zhang, J ;
Martignetti, JA ;
Bromme, D ;
Desnick, RJ .
BIOCHEMICAL AND MOLECULAR MEDICINE, 1996, 59 (02) :200-206
[9]   Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption [J].
Inui, T ;
Ishibashi, O ;
Inaoka, T ;
Origane, Y ;
Kumegawa, M ;
Kokubo, T ;
Yamamura, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) :8109-8112
[10]   A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis [J].
Johnson, MR ;
Polymeropoulos, MH ;
Vos, HL ;
deLuna, RIO ;
Francomano, CA .
GENOME RESEARCH, 1996, 6 (11) :1050-1055